AngioDynamics ANGO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$33.99M+81.6% | -$184.35M-252% | -$52.44M-57.6% | -$33.29M-5.5% | ||
| $25.8M-6.9% | $27.71M-10.2% | $30.87M+5.2% | $29.35M+13.2% | ||
| $9.77M-7.2% | $10.53M-5.6% | $11.16M+4.4% | $10.69M+24.0% | ||
| —— | —— | —— | —— | ||
| $0— | —— | $0-100% | $97K+1,070% | ||
| $699K-47.3% | $1.33M+90.8% | $695K+489% | $118K— | ||
| —— | —— | —— | $17.15M— | ||
| —— | —— | —— | $2.8M+124% | ||
| —— | $27.53M+1,187% | $2.14M-45.3% | $3.91M— | ||
| -$3.09M-127% | $11.59M— | —— | —— | ||
| -$293K-573% | $62K— | —— | —— | ||
| —— | —— | —— | —— | ||
| $4.46M+77.3% | $2.52M-33.9% | $3.81M-11.3% | $4.3M-17.2% | ||
| -$10.18M— | —— | -$9.75M+49.5% | -$19.31M-40.8% | ||
| —— | $0— | $0— | —— | ||
| —— | —— | —— | —— | ||
| $148K— | —— | $0— | —— | ||
| -$255K+99.6% | -$64.94M-355% | $25.42M+231% | $7.68M+145% | ||
| $398K— | —— | —— | -$535K-252% | ||
| —— | $33.83M+114% | $15.8M— | —— | ||
| $185K— | $0-100% | $2.58M+359% | $562K-23.1% | ||
| $800K+75.8% | $455K+33.0% | $342K+4.0% | $329K+5.1% | ||
| $272K-37.0% | $432K-81.4% | $2.32M+91.4% | $1.21M+1,262% | ||
| —— | —— | —— | —— | ||
| -$988K+87.6% | -$7.97M-245% | -$2.31M+37.7% | -$3.71M+22.8% | ||
| $0-100% | $54.5M— | $0— | $0— | ||
| —— | —— | —— | —— | ||
| -$3.09M-127% | $11.59M— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $1.96M+1.4% | $1.93M-22.3% | $2.48M+1.8% | $2.44M-0.7% | ||
| -$293K-573% | $62K— | —— | —— | ||
| $699K-47.3% | $1.33M+90.8% | $695K+489% | $118K— | ||
| $0+100% | -$5.08M— | $0— | $0— | ||
| $5.71M+13.9% | $5.02M-7.0% | $5.39M-52.7% | $11.41M+33.9% | ||
| $0-100% | $3.25M+502% | $540K— | $0— | ||
| $148K— | —— | $0— | —— | ||
| —— | —— | —— | —— | ||
| $933K+24.1% | $752K-35.8% | $1.17M-56.4% | $2.68M-11.0% | ||
| $185K— | $0-100% | $2.58M+359% | $562K-23.1% | ||
| -$49K+37.2% | -$78K— | —— | —— | ||
| —— | —— | —— | —— | ||
| $0— | $0-100% | $70M— | $0— | ||
| $6.31M— | —— | $0— | —— | ||
| $800K+75.8% | $455K+33.0% | $342K+4.0% | $329K+5.1% | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AngioDynamics generate?
- AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
- What is AngioDynamics's free cash flow?
- After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
- Where does AngioDynamics's cash flow data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
